Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Chondrosarcoma × TQ-B3525 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer 1 Chondrosarcoma 1

Interventions

Doxorubicin 2 spartalizumab 1 nilotinib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 envafolimab 1 Trabectedin 1 TQ-B3525 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Heavy Ion Radiotherapy 1 Gelclair 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04690725 2020-12-31

TQBSP

Peking University People's Hospital

Phase 1/2 Unknown

Chondrosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡